Free Trial
NASDAQ:MNOV

MediciNova (MNOV) Stock Price, News & Analysis

MediciNova logo
$1.27 +0.01 (+0.41%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About MediciNova Stock (NASDAQ:MNOV)

Key Stats

Today's Range
$1.26
$1.29
50-Day Range
$1.25
$1.53
52-Week Range
$1.12
$2.55
Volume
15,348 shs
Average Volume
36,520 shs
Market Capitalization
$62.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Strong Buy

Company Overview

MediciNova Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
33rd Percentile Overall Score

MNOV MarketRank™: 

MediciNova scored higher than 33% of companies evaluated by MarketBeat, and ranked 774th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MediciNova has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    MediciNova has only been the subject of 1 research reports in the past 90 days.

  • Read more about MediciNova's stock forecast and price target.
  • Earnings Growth

    Earnings for MediciNova are expected to remain at ($0.24) per share in the coming year.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MediciNova is -5.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MediciNova is -5.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MediciNova has a P/B Ratio of 1.20. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about MediciNova's valuation and earnings.
  • Percentage of Shares Shorted

    0.36% of the float of MediciNova has been sold short.
  • Short Interest Ratio / Days to Cover

    MediciNova has a short interest ratio ("days to cover") of 12.4, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in MediciNova has recently increased by 2.46%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    MediciNova does not currently pay a dividend.

  • Dividend Growth

    MediciNova does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.36% of the float of MediciNova has been sold short.
  • Short Interest Ratio / Days to Cover

    MediciNova has a short interest ratio ("days to cover") of 12.4, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in MediciNova has recently increased by 2.46%, indicating that investor sentiment is decreasing.
  • News Sentiment

    MediciNova has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for MediciNova this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, MediciNova insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    13.60% of the stock of MediciNova is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 9.90% of the stock of MediciNova is held by institutions.

  • Read more about MediciNova's insider trading history.
Receive MNOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MediciNova and its competitors with MarketBeat's FREE daily newsletter.

MNOV Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
MediciNova says first patient enrolled in EAP trial to evaluate MN-166
See More Headlines

MNOV Stock Analysis - Frequently Asked Questions

MediciNova's stock was trading at $2.10 on January 1st, 2025. Since then, MNOV shares have decreased by 39.0% and is now trading at $1.28.

MediciNova, Inc. (NASDAQ:MNOV) released its quarterly earnings results on Tuesday, May, 13th. The biopharmaceutical company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.14) by $0.08.

Shares of MNOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MediciNova investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NIO (NIO), AST SpaceMobile (ASTS), Virgin Galactic (SPCE) and Inuvo (INUV).

Company Calendar

Last Earnings
5/13/2025
Today
7/14/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MNOV
CIK
1226616
Employees
10
Year Founded
2000

Price Target and Rating

High Price Target
$9.00
Low Price Target
$5.00
Potential Upside/Downside
+446.9%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$11.04 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-20.77%
Return on Assets
-19.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
17.66
Quick Ratio
17.66

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.07 per share
Price / Book
1.20

Miscellaneous

Outstanding Shares
49,046,000
Free Float
42,376,000
Market Cap
$62.78 million
Optionable
Optionable
Beta
0.40

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:MNOV) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners